Does fitness predict a longer life?
High vs low fitness: all-cause death HR 0.47 to 0.59, about 11-17% lower per 1 MET. Cohorts, usually one test, mostly men, no athletes: a strong predictor, not proof training buys it.
The authors searched five databases to March 2024 and took each outcome from reviews with little overlap in their primary studies, choosing the best-rated review where overlap was high. They split evidence into mortality in general populations (8 reviews, 95 cohorts), new disease (9 reviews, 63 cohorts) and prognosis with existing disease (9 reviews, 51 cohorts).
Fitness predicted almost every outcome. The authors say the results may signal a causal relationship, and call fitness strongly protective; both are their reading. They also state that the evidence was limited to associations with a single fitness measure.
Protocol
Key Results
| Outcome (general populations unless stated) | High vs low fitness, HR (95% CI) | Per 1 MET higher, HR (95% CI) |
|---|---|---|
| All-cause mortality | 0.47 (0.39 to 0.56) to 0.59 (0.52 to 0.66) | 0.89 (0.86 to 0.92) to 0.83 (0.78 to 0.88) |
| Sudden cardiac mortality | — | 0.49 (0.33 to 0.73); 2 studies |
| All cancer mortality | — | 0.93 (0.91 to 0.96) |
| New heart failure | 0.31 (0.19 to 0.49) | 0.82 (0.79 to 0.84) |
| New hypertension | 0.63 (0.56 to 0.70) | — |
| New stroke | — | 0.97 (0.96 to 0.98) |
| Cardiovascular death, people with cardiovascular disease | 0.27 (0.16 to 0.48) | — |
| Adverse events, pulmonary hypertension | 0.81 (0.78 to 0.85) | — |
Mechanisms
Practical Application
Limitations
How this entry was checked and changed
an overview of meta-analyses of cohorts is not a meta-analysis of controlled trials, so its size does not lift it above the observational cap; 11 of the 26 reviews were rated critically low quality on AMSTAR2 and only 3 high